462 related articles for article (PubMed ID: 17089839)
1. In vivo and phantom measurements of the secondary photon and neutron doses for prostate patients undergoing 18 MV IMRT.
Reft CS; Runkel-Muller R; Myrianthopoulos L
Med Phys; 2006 Oct; 33(10):3734-42. PubMed ID: 17089839
[TBL] [Abstract][Full Text] [Related]
2. Whole-body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy.
Hauri P; Schneider U
J Appl Clin Med Phys; 2019 Mar; 20(3):56-70. PubMed ID: 30791198
[TBL] [Abstract][Full Text] [Related]
3. Constituent components of out-of-field scatter dose for 18-MV intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy: a comparison with 6-MV and implications for carcinogenesis.
Ruben JD; Smith R; Lancaster CM; Haynes M; Jones P; Panettieri V
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(3):645-53. PubMed ID: 25084609
[TBL] [Abstract][Full Text] [Related]
4. Out-of-field photon and neutron dose equivalents from step-and-shoot intensity-modulated radiation therapy.
Kry SF; Salehpour M; Followill DS; Stovall M; Kuban DA; White RA; Rosen II
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1204-16. PubMed ID: 15990026
[TBL] [Abstract][Full Text] [Related]
5. Incidental testicular irradiation from prostate IMRT: it all adds up.
King CR; Maxim PG; Hsu A; Kapp DS
Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):484-9. PubMed ID: 19733013
[TBL] [Abstract][Full Text] [Related]
6. Peripheral photon and neutron doses from prostate cancer external beam irradiation.
Bezak E; Takam R; Marcu LG
Radiat Prot Dosimetry; 2015 Dec; 167(4):591-601. PubMed ID: 25564673
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Photoneutron Dose Measured by Bubble Detectors in Conventional Linacs and Cyberknife Unit: Effective Dose and Secondary Malignancy Risk Estimation.
Biltekin F; Yeginer M; Ozyigit G
Technol Cancer Res Treat; 2016 Aug; 15(4):560-5. PubMed ID: 26152750
[TBL] [Abstract][Full Text] [Related]
8. Commissioning of intensity modulated neutron radiotherapy (IMNRT).
Burmeister J; Spink R; Liang L; Bossenberger T; Halford R; Brandon J; Delauter J; Snyder M
Med Phys; 2013 Feb; 40(2):021718. PubMed ID: 23387741
[TBL] [Abstract][Full Text] [Related]
9. Measurements of the neutron dose equivalent for various radiation qualities, treatment machines and delivery techniques in radiation therapy.
Hälg RA; Besserer J; Boschung M; Mayer S; Lomax AJ; Schneider U
Phys Med Biol; 2014 May; 59(10):2457-68. PubMed ID: 24778349
[TBL] [Abstract][Full Text] [Related]
10. Measurements of secondary neutron dose from 15 MV and 18 MV IMRT.
Howell RM; Ferenci MS; Hertel NE; Fullerton GD; Fox T; Davis LW
Radiat Prot Dosimetry; 2005; 115(1-4):508-12. PubMed ID: 16381776
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the secondary neutron field produced during treatment of an anthropomorphic phantom with x-rays, protons and carbon ions.
Tessa CL; Berger T; Kaderka R; Schardt D; Burmeister S; Labrenz J; Reitz G; Durante M
Phys Med Biol; 2014 Apr; 59(8):2111-25. PubMed ID: 24694920
[TBL] [Abstract][Full Text] [Related]
12. Calculation of effective dose from measurements of secondary neutron spectra and scattered photon dose from dynamic MLC IMRT for 6 MV, 15 MV, and 18 MV beam energies.
Howell RM; Hertel NE; Wang Z; Hutchinson J; Fullerton GD
Med Phys; 2006 Feb; 33(2):360-8. PubMed ID: 16532941
[TBL] [Abstract][Full Text] [Related]
13. Investigation of secondary neutron dose for 18 MV dynamic MLC IMRT delivery.
Howell RM; Ferenci MS; Hertel NE; Fullerton GD
Med Phys; 2005 Mar; 32(3):786-93. PubMed ID: 15839351
[TBL] [Abstract][Full Text] [Related]
14. SU-E-T-263: Luminescent Dosimetry to Measure the Out-Of-Field Low and High LET Dose Components in High Energy Photon and Proton Therapy Beams.
Reft C
Med Phys; 2012 Jun; 39(6Part13):3764. PubMed ID: 28517336
[TBL] [Abstract][Full Text] [Related]
15. The effect of beam energy on the quality of IMRT plans for prostate conformal radiotherapy.
de Boer SF; Kumek Y; Jaggernauth W; Podgorsak MB
Technol Cancer Res Treat; 2007 Apr; 6(2):139-46. PubMed ID: 17375977
[TBL] [Abstract][Full Text] [Related]
16. The impact of IMRT and proton radiotherapy on secondary cancer incidence.
Schneider U; Lomax A; Pemler P; Besserer J; Ross D; Lombriser N; Kaser-Hotz B
Strahlenther Onkol; 2006 Nov; 182(11):647-52. PubMed ID: 17072522
[TBL] [Abstract][Full Text] [Related]
17. Comparison of out-of-field photon doses in 6 MV IMRT and neutron doses in proton therapy for adult and pediatric patients.
Athar BS; Bednarz B; Seco J; Hancox C; Paganetti H
Phys Med Biol; 2010 May; 55(10):2879-91. PubMed ID: 20427856
[TBL] [Abstract][Full Text] [Related]
18. Calculated organ doses from selected prostate treatment plans using Monte Carlo simulations and an anatomically realistic computational phantom.
Bednarz B; Hancox C; Xu XG
Phys Med Biol; 2009 Sep; 54(17):5271-86. PubMed ID: 19671968
[TBL] [Abstract][Full Text] [Related]
19. Study on surface dose generated in prostate intensity-modulated radiation therapy treatment.
Chow JC; Grigorov GN; Barnett RB
Med Dosim; 2006; 31(4):249-58. PubMed ID: 17134664
[TBL] [Abstract][Full Text] [Related]
20. Photonuclear dose calculations for high-energy photon beams from Siemens and Varian linacs.
Chibani O; Ma CM
Med Phys; 2003 Aug; 30(8):1990-2000. PubMed ID: 12945965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
